BlackThorn Therapeutics Company
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Investors
.png)
.jpg)
(Reupload).png)
(Reupload).png)
Technology:
Genetic Test & Molecular Diagnostics
Industry:
Artificial Intelligence, Biotechnology, Clinical development, End-to-end Drug Development, Health Care, Therapeutics
Headquarters:
San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
14
Total Funding:
138000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-06-13
Last Funding Type:
Series B
Register and Claim Ownership